Pain – NSAIDS

  • Duexis 2015 report

    Duexis 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 35 Pages The 5 Key Questions Addressed by this...

  • Flector Patch 2015 report

    Flector Patch 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 27 Pages The 5 Key Questions Addressed by...

  • Ofirmev 2015 report

    Ofirmev 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 27 Pages The 5 Key Questions Addressed by this...

  • Pennsaid 2015 report

    Pennsaid 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 31 Pages The 5 Key Questions Addressed by this...

  • Sprix 2015 report

    Sprix 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 31 Pages The 5 Key Questions Addressed by this...

  • Tivorbex 2015 report

    Tivorbex 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 31 Pages The 5 Key Questions Addressed by this...

  • Voltaren Gel 2015 report

    Voltaren Gel 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 35 Pages The 5 Key Questions Addressed by...

  • Zipsor 2015 report

    Zipsor 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 31 Pages The 5 Key Questions Addressed by this...

  • Zorvolex 2015 report

    Zorvolex 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 31 Pages The 5 Key Questions Addressed by this...

  • Caldolor 2014 report

    Caldolor 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 25 Pages The 5 Key Questions Addressed by this...

  • Celebrex 2014 report

    Celebrex 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 29 Pages The 5 Key Questions Addressed by this...

  • Duexis 2014 report

    Duexis 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 33 Pages The 5 Key Questions Addressed by this...